An observational study in Gastric Cancer, sponsored by Nanjing Medical University. Completed at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2022-06-01.
Sponsored by Nanjing Medical University · Observational
The incidence of complications after gastrectomy remains high among elderly patients with gastric cancer. The investigators sought to establish and validate a web-based nomorgam for predicting total complications among elderly patients undergoing resection of gastric cancer.
2,850 studies on the registry are indexed under Stomach Neoplasms; 863 are open to participants now.
This study's enrollment of 582 is above the median of 274 across 670 observational studies indexed under Stomach Neoplasms.
Browse Stomach Neoplasms studies →Nanjing Medical University is the lead sponsor of 169 studies on the registry; 51 are open to participants now.
Counted across the registry records on this site, refreshed daily.
elderly gastric cancer patients
Exclusion Criteria:
The training cohort was used for data analysis.
Other: data analysis; validating the nomogram
The validation cohort was used for validating the nomogram
Other: data analysis; validating the nomogram
Not Applicable. Our study did not involve intervention
postoperative complications during hospitalization
the investigators captured it from electronic medical records
Time frame: about 3 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanjing Medical University